Media Coverage

Enveric Biosciences Files Provisional Patent for Cannabinoid + Celecoxib Conjugate EV104 after Successful Synthesis [IPO Edge]

By EnvericFebruary 8, 2022No Comments

https://finance.yahoo.com/news/enveric-biosciences-files-provisional-patent-214536823.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZW52ZXJpYy5jb20v&guce_referrer_sig=AQAAAIp7hCuGPXC1J-RCbbPJx9NsQx6Vv_FJkaRKGgsvfN6gOH4gXdA-Asvck2OuCViP4Xuk_XgLTMWBu2e4cKprhWS4Yo9pSGsXuXEBVV9JhnthUovjabluWHepMDqRGj14_EPIjnoXICNk8rB_uf_w13TzI_r9DobeVVdjBEjOFbD6

You must be logged in to post a comment.

Enveric Biosciences is a development stage company that markets no products at this time. The content of this site is not intended to be promotional or to suggest any product or use of a product that has been approved by any regulatory body.

Enveric Biosciences Files Provisional Patent for Cannabinoid + Celecoxib Conjugate EV104 after Successful Synthesis [IPO Edge]

Leave a Reply

Company

Team

Psybrary™

Pipeline

Investors

Contact